A neurologist’s perspective on serum neurofilament light in the memory clinic: a prospective implementation study
Abstract Background Neurofilament light in serum (sNfL) is a biomarker for axonal damage with elevated levels in many neurological disorders, including neurodegenerative dementias. Since within-group variation of sNfL is large and concentrations increase with aging, sNfL’s clinical use in memory cli...
Main Authors: | E. A. J. Willemse, P. Scheltens, C. E. Teunissen, E. G. B. Vijverberg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-021-00841-4 |
Similar Items
-
Blood Neurofilament Light Chain: The Neurologist’s Troponin?
by: Simon Thebault, et al.
Published: (2020-11-01) -
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
by: Andre Strydom, et al.
Published: (2018-04-01) -
Predictive value of serum neurofilament light chain for persistent cognitive deficits in elderly depressive patients
by: Christoph Linnemann, et al.
Published: (2021-04-01) -
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
by: Piotr Lewczuk, et al.
Published: (2018-07-01) -
Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
by: Quan-Fu Li, et al.
Published: (2019-11-01)